Navigation Links
FDA Approves Vaccines for 2009 H1N1 Influenza Virus
Date:9/15/2009

Approval Provides Important Tool to Fight Pandemic

WASHINGTON, Sept. 15 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO )

"Today's approval is good news for our nation's response to the 2009 H1N1 influenza virus," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "This vaccine will help protect individuals from serious illness and death from influenza."

The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. All four firms manufacture the H1N1 vaccines using the same processes, which have a long record of producing safe seasonal influenza vaccines.

"The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines," said Jesse Goodman, M.D., FDA acting chief scientist.

Based on preliminary data from adults participating in multiple clinical studies, the 2009 H1N1 vaccines induce a robust immune response in most healthy adults eight to 10 days after a single dose, as occurs with the seasonal influenza vaccine.

Clinical studies under way will provide additional information about the optimal dose in children. The recommendations for dosing will be updated if indicated by findings from those studies. The findings are expected in the near future.

As with the seasonal influenza vaccines
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... “The SWEET Act is an important step to invigorate ... help parents who are working to reduce sugar in their ... support public health, and we will continue to stand on ... all families,” said Dr. Jane Delgado President and CEO of ... the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa L. ...
(Date:3/26/2015)... Greenwod Village, CO (PRWEB) March 26, 2015 ... to providing help where it is most needed but ... Moses supplies therapeutic milk to six clinics in the ... suffering from severe malnutrition. During a recent visit to ... reach out to the mothers and their babies in ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Dr. Alex ... proud to announce expanded offerings for Bay Area patients ... Dental Implant Center has long been a top-rated center, ... its offerings to meet the strong demand by others ... reputation as a top-rated dental implant facility in San ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Pacific ... repairs, is pleased to be featured on Innovations with ... on March 18, 2015. The episode will repeat ... is live on the Pacific Medical home page at: ... life threatening emergencies, it is reassuring to trust the ...
(Date:3/26/2015)... BioPlus Specialty Pharmacy ... pharmacies, announces the promotion of Sharon Ferrer to ... Pharmaceutical Relations. In this position, Ferrer will be ... partners and providing key leadership in building and ... , “Over the past seven years that ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... Breast cancer patients 35 years old and younger have ... older women patients with the same stage of cancer, ... the type of treatment they received, according to a ... Radiation Oncology*Biology*Physics , the official journal of the American ...
... for Healthcare Philanthropy (AHP) today issued the following ... donations proposed in the Obama Administration,s budget:The Association ... the President,s budget that would impose new limits ... efforts in the budget to revive the economy, ...
... 4 The following statement in response to today,s ... director of the New Jersey Lawsuit Reform Alliance."We are ... certain to open the floodgates to new lawsuits around ... that 50 state courts with different rules and standards ...
... CVS Caremark Corporation (NYSE: CVS ) today ... quarterly dividend of $0.07625 per share on the Common ... holders of record on April 22, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ... of prescriptions in the nation. The Company fills or ...
... French . , Montreal, March 4th, 2009 ... actually a hormone produced by our own bodies, and it ... a new study published in the journal Stem Cells ... Health Centre explain that tweaking a certain group of multipotent ...
... University of California, San Francisco has shown that ... of mortality among breast cancer patients, especially those ... approximately 30 percent of the survival disparity between ... to the study,s lead author, UCSF epidemiologist Dejana ...
Cached Medicine News:Health News:Younger breast cancer patients have greater chance of recurrence 2Health News:Association for Healthcare Philanthropy Opposes Limits on Charitable Tax Deductions 2Health News:Association for Healthcare Philanthropy Opposes Limits on Charitable Tax Deductions 3Health News:Stem cells could halt osteoporosis, promote bone growth 2Health News:High blood pressure linked to earlier death among African-American breast cancer patients 2Health News:High blood pressure linked to earlier death among African-American breast cancer patients 3
(Date:3/26/2015)... , March 26, 2015  The inaugural ... the use of health technology innovations that improve ... foster collaborations to improve development and adoption of ... the structures and processes within delivery systems that ... providers, investors, entrepreneurs, developers and other stakeholders, takes ...
(Date:3/26/2015)... , March 26, 2015 ... "Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse ... On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, ... by MarketsandMarkets, the Pharmacovigilance and Drug Safety Software ... of 6.5% during 2014-2019, and is expected to ...
(Date:3/26/2015)... -- Flexpoint Sensor Systems, Inc. (OTCBB: FLXT) today announced several ... shipped during the last 90 days. Flexpoint ... sensors for gloves and medical uses. Several new customers ... built for them. Some of these new clients include ... rehab; a major international electronics manufacturer who is using ...
Breaking Medicine Technology:HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 2HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... precise episcleral, intrascleral, and intraocular hemostasis ... Rf diathermy delivers targeted coagulation with ... Eraser instruments, forceps and cables. This ... a high level of Wet-Field safety ...
Medicine Products: